How to buy Inari Medical stock - 07 March
finder.com
US
AU
NZ
UK
CA
SG
More

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Inari Medical stock

Own Inari Medical stock in just a few minutes.

Jing Jun Ma
Jing Jun Ma

Posted

Fact checked
Buy Inari Medical (NARI) Learn more

Inari Medical, Inc is a medical devices business based in the US. Inari Medical shares (NARI) are listed on the NASDAQ and all prices are listed in US Dollars. Inari Medical employs 199 staff and has a trailing 12-month revenue of around USD$110.9 million.

How to buy shares in Inari Medical

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Inari Medical. Find the stock by name or ticker symbol: NARI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Inari Medical reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Inari Medical, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Inari Medical. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

What's in this guide?

  1. NARI shares summary
  2. Compare share dealing platforms
  3. Is NARI stock a buy or sell?
  4. Stock performance over time
  5. Can I short NARI shares?
  6. Are NARI shares over-valued?
  7. Inari Medical's financials
  8. Does Inari Medical pay a dividend?
  9. Other common questions

Inari Medical share price

Use our graph to track the performance of NARI stocks over time.

Inari Medical shares at a glance

Information last updated 2021-03-03.
52-week rangeUSD$39.55 - USD$120
50-day moving average USD$105.9277
200-day moving average USD$80.1734
Wall St. target priceUSD$107
PE ratio 461.9661
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.1242

Buy Inari Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Go to site
More Info
Webull
Webull
$0
Stocks, Options, ETFs
$0
0%
Get two free stock valued between $2.50 and $250
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Go to site
More Info
TradeStation
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Go to site
More Info
Tastyworks
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Go to site
More Info
Interactive Brokers
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Go to site
More Info
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Inari Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Inari Medical, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Inari Medical under- or over-valued?

Valuing Inari Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inari Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Inari Medical's P/E ratio

Inari Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 462x. In other words, Inari Medical shares trade at around 462x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Inari Medical's EBITDA

Inari Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$15 million.

The EBITDA is a measure of a Inari Medical's overall financial performance and is widely used to measure a its profitability.

Inari Medical financials

Revenue TTM USD$110.9 million
Operating margin TTM 12.45%
Gross profit TTM USD$45.3 million
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 6.45%
Book value N/A
Market capitalisation USD$5.4 billion

TTM: trailing 12 months

Shorting Inari Medical shares

There are currently 718,039 Inari Medical shares held short by investors – that's known as Inari Medical's "short interest". This figure is 4.2% down from 749,296 last month.

There are a few different ways that this level of interest in shorting Inari Medical shares can be evaluated.

Inari Medical's "short interest ratio" (SIR)

Inari Medical's "short interest ratio" (SIR) is the quantity of Inari Medical shares currently shorted divided by the average quantity of Inari Medical shares traded daily (recently around 535850). Inari Medical's SIR currently stands at 1.34. In other words for every 100,000 Inari Medical shares traded daily on the market, roughly 1340 shares are currently held short.

However Inari Medical's short interest can also be evaluated against the total number of Inari Medical shares, or, against the total number of tradable Inari Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Inari Medical's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Inari Medical shares in existence, roughly 10 shares are currently held short) or 0.04% of the tradable shares (for every 100,000 tradable Inari Medical shares, roughly 40 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Inari Medical.

Find out more about how you can short Inari Medical stock.

Inari Medical share dividends

We're not expecting Inari Medical to pay a dividend over the next 12 months.

Inari Medical overview

Inari Medical, Inc., a commercial-stage medical device company, focuses on developing products to treat and transform the lives of patients suffering from venous diseases in the United States. It produces ClotTriever for treatment of deep vein thrombosis; and FlowTriever, a thrombectomy system for treatment of pulmonary embolism. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was founded in 2011 and is headquartered in Irvine, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site